NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension

Hypertension

Volumn 42, Issue 3, 2003, Pages 316-321

  Li, Lixin ^b   Watts, Stephanie W ^b   Banes, Amy K ^b   Galligan, James J ^b   Fink, Gregory D ^b   Chen, Alex F ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Endothelin; Hypertension, mineralocorticoid; Oxidative stress; Venoconstriction

Indexed keywords

APOCYNIN; ATRASENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR AGONIST; MINERALOCORTICOID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SARAFOTOXIN S6C; SCAVENGER; SUPEROXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CAVA VEIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VENOCONSTRICTION;

ACETOPHENONES; ALLOPURINOL; ANIMALS; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; HYPERTENSION; MALE; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RECEPTORS, MINERALOCORTICOID; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VENAE CAVAE; VIPER VENOMS; XANTHINE OXIDASE;

EID: 0041331782     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000084853.47326.F2     Document Type: Article

References (29)

1. Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens. 2000;14:343-345.
2. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
3. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension. 2001;37:77-83.
4. Martin DS, Rodrigo MC, Appelt CW. Venous tone in the developmental stages of spontaneous hypertension. Hypertension. 1998;31:139-144.
5. Monos E, Berczi V, Nadasy G. Local control of veins: biomechanical, metabolic and humoral aspects. Physiol Rev. 1995;75:611-666.
6. Waite RP, Pang CY. Effect of endothelin on arterial pressure and venous tone in the intact and hexamethonium-treated, conscious rat. J Cardiovasc Pharmacol. 1990;16:940-944.
7. Rizzi A, Quaglio D, Vasquez G, Mascoli F, Amadesi S, Calo G, Regoli D, Zamboni P. Effects of vasoactive agents in healthy and diseased human saphenous veins. J Vasc Surg. 1998;28:855-861.
8. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
9. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation. 2000;101:1722-1728.
10. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38:1107-1111.
11. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 2001;19: 741-748.
12. Li LX, Crockett E, Wang DH, Galligan JJ, Fink GD, Chen AF. Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol. 2002;22:249-255.
13. A-NADPH oxidase pathway in low renin hypertension. Circulation. 2003;107:1053-1058.
14. Li LX, Galligan JJ, Fink GD, Chen AF. Vasopressin enhances vascular superoxide production by activating endothelin-1 in mineralocorticoid hypertension. Hypertension. 2003;41(pt 2):663-668.
15. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res. 1975;36:300-309.
16. Lariviere R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
17. Matsumura Y, Hashimoto N, Taira S, Kuto T, Kitano R, Ohkita M, Opqenorth TJ, Takaoka M. Different contribution of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension. 1999;33: 759-765.
18. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol: Heart Circ Physiol. 2002;283:H885-H892.
19. Johnson RJ, Fink GD, Watts SW, Galligan JJ. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats. J Hypertens. 2002;20:665-676.
20. Watts SW, Fink GD, Northcott CA, Galligan JJ. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension: studies with receptor agonists. Br J Pharmacol. 2002;137:69-79.
21. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864.
22. Cosentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension. 1994; 23:229-235.
23. Wedgwood S, McMullan M, Bekker JM, Fineman JR, Black SM. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res. 2001;89:357-364.
24. Ricksten SE, Yao T, Thoren P. Peripheral and central vascular compliances in conscious normotensive and spontaneously hypertensive rats. Acta Physiol Scand. 1981;112:169-177.
25. Safar ME, London GM. Arterial and venous compliance in sustained essential hypertension. Hypertension. 1987;10:133-139.
26. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96:3264-3265.
27. Kojda G, Harrison D. Interaction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562-571.
28. Landmesser U, Harrison DG. Oxidant stress as a marker for cardiovascular events: Ox marks the spot. Circulation. 2001;104:2638-2640.
29. Meyer JW, Schmitt ME. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 2000;472:1-4.